| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ATRI | common stock | Disposed to Issuer | -$25.5M | -55.5K | -100% | $460.00 | 0 | Aug 21, 2024 | By Family Trust | F1 |
| transaction | ATRI | common stock | Award | $0 | +1.28K | +3.24% | $0.00 | 40.7K | Aug 21, 2024 | Direct | F2 |
| transaction | ATRI | common stock | Disposed to Issuer | -$18.7M | -40.7K | -100% | $460.00 | 0 | Aug 21, 2024 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ATRI | restricted stock units | Disposed to Issuer | $0 | -1.16K | -100% | $0.00 | 0 | Aug 21, 2024 | common stock | 1.16K | $0.00 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Disposed of as a result of the merger pursuant to the previously announced Agreement and Plan of Merger, dated as of May 28, 2024, by and among Nordson Corporation, Alpha Medical Merger Sub, Inc., a wholly owned subsidiary of Nordson, and Atrion Corporation. At the effective time of the Merger, (i) each issued and outstanding share of common stock and (ii) each restricted stock unit, performance-based stock unit and deferred stock unit, were thereupon canceled and converted into the right to receive $460.00 in cash. |
| F2 | This amount represents performance stock units previously granted to the Reporting Person that vested in connection with the Merger. |